GKE 595

Original report: PDF p. 69 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 70 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 71 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 71 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 72 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 72 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 73 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 74 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 75 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 75 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 76 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 77 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 98 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 98 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 112 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 108 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 108 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 62 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 63 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 64 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 64 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 65 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 65 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 67 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 68 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 69 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 70 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 89 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 89 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 102 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 63 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 64 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 65 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 65 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 66 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 66 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 68 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 69 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 70 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 71 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 90 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 90 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 103 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 129 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 63 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 64 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 65 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 65 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 66 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 66 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 68 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 69 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 70 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 71 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 93 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.

Group income, comprehensive income and cash-flow statements, and Group/Company balance sheets and changes in equity are printed. Separate Company income, comprehensive-income and cash-flow primary statements are not printed.

Annual addenda dated 10 September 2026 and 10 September 2025 seek renewal of the Share Purchase Mandate and IPT General Mandate. Their illustrative financial effects are not replacement audited balances. The FY2025 addendum cover date is 10 September 2025 while its SGX broadcast is 9 September 2025; document and announcement dates remain distinct.

Original report: PDF p. 93 ↗

Five full financial years FY2022–FY2026 end on 31 May. Latest comparative presentation: FY2026 annual supplies 2026/2025, FY2025 supplies 2024, FY2024 supplies 2023, and FY2023 supplies 2022. Five annual originals total 753 pages; two separately archived mandate addenda total 64 pages.

Statement money is Singapore dollars in thousands ($’000). EPS is Singapore cents per share; weighted average share denominators in Note 9 are thousands of ordinary shares excluding treasury. The original FY2024 comparative cash-flow fair-value-loss cell is printed −*; its footnote says less than $1,000. The displayed * retains that bound and does not assert an exact zero.

FY2024 Note 34 re-presents FY2023 cost of sales from 78,426 to 77,321 and administrative expenses from 21,930 to 23,035 (S$’000). Deferred tax assets increase 491 and deferred tax liabilities increase 491; total assets and liabilities each increase 491, with equity and net profit unchanged. FY2023 Note 34 re-presents FY2022 cost of sales from 78,526 to 78,976 and administrative expenses from 16,959 to 16,509. Both original bridges are shown; these are disclosed reclassifications.

FY2026 Group net profit 3,096 comprises owners profit 3,234 and NCI loss 138 (S$’000). Current Group equity includes NCI; historical equity retains the printed cash-flow-hedge reserve column. Group and Company component columns keep their original year and scope.

GKE Retails is a consolidated subsidiary with 60% Group interest and 40% NCI after the 27 June 2025 transaction, despite the contract title Joint Venture Agreement. The printed superscript footnote 1 after 60 is not 601%. External subscription consideration was $666,667 in cash and assets; consolidated cash flow reports 400 (S$’000) cash. The source equity statement separately reports 551 NCI and 116 capital reserve, total 667 (S$’000). These are distinct scopes.

FY2026 Note 9 prints basic and diluted denominators 827,965 and 832,849 thousand shares, an increment of 4,884 thousand. Its narrative says 4,618,000 share options were considered. Both original disclosures are retained; that EPS note provides no bridge for the difference. Original basic and diluted EPS both round to 0.39 cents using the printed denominators.

Current Ernst & Young LLP audit, engagement partner Lim Huijing Amanda, dated 31 August 2026, expresses a true and fair opinion. This is the opinion in this issuer’s original report.